View
2
Download
0
Category
Preview:
Citation preview
COURSE 1: The Negotiation Masterclass –Improving The Probability of Success
08:00 - 17:00EBD Academy: COURSE 1
// ADDITIONAL REGISTRATION FEE //
The Negotiation Masterclass – Improving TheProbability of Success takes place on March 23 -24 ,Vienna, Austria ahead of BIO-Europe Spring. It is aninteractive two-day workshop for businessdevelopment professionals who want to becomestrong and successful negotiators in high valuenegotiations.
LEARN MORE »
SESSIONSPRE-EVENT PROGRAMS - 23/03/2019
BIO-Europe SpringMarch 25–27, 2019
Messe Wien Exhibition and Congress CenterVienna, Austria
+49 89 2388 756 0 ebdgroup.knect365.com/bioeurope-spring/ conferences@ebdgroup.com
TIME EBD ACADEMY: COURSE 1
08:00 08:00 - COURSE 1: The Negotiation Masterclass – Improving The Probability of Success
SCHEDULEPRE-EVENT PROGRAMS - 23/03/2019
BIO-Europe SpringMarch 25–27, 2019
Messe Wien Exhibition and Congress CenterVienna, Austria
+49 89 2388 756 0 ebdgroup.knect365.com/bioeurope-spring/ conferences@ebdgroup.com
COURSE 1 Continued: The NegotiationMasterclass – Improving The Probability ofSuccess
08:00 - 17:00EBD Academy: COURSE 1
// ADDITIONAL REGISTRATION FEE //
The Negotiation Masterclass – Improving TheProbability of Success takes place on March 23 -24 ,Vienna, Austria ahead of BIO-Europe Spring. It is aninteractive two-day workshop for businessdevelopment professionals who want to becomestrong and successful negotiators in high valuenegotiations.
LEARN MORE »
COURSE 2: Product Valuation & DealStructuring Masterclass
08:30 - 17:30EBD Academy: COURSE 2
// ADDITIONAL REGISTRATION FEE //
The Product Valuation & Deal Structuring Masterclasstakes place on March 24, Vienna, Austria ahead ofBIO-Europe Spring. It is an intensive one-day workshopfor business development professionals who want tomaximize their product valuation and deal structuringskills to gain a competitive advantage whennegotiating a deal.
LEARN MORE »
EUROPE CEO
09:00 - 19:00Leading Biotech
Stay at the forefront of European biotechdevelopments in an intimate setting unlike anotherother
REQUEST YOUR EXCLUSIVE INVITATION
Registration open
14:00 - 19:00Main Agenda
Level 0, Foyer A
Registration open (at the conference center) - Pick upname badges
Welcome Reception
19:00 - 21:00Networking
LOCATION:Vienna City HallFriedrich-Schmidt-Platz 1Entrance: Lichtenfelsgasse 2Feststiege 11010 Vienna
All BIO-Europe Spring attendees are cordially invited tojoin us for the welcome reception. You will be able topick up your name badge at the welcome receptionbetween 19:00-21:00.
Friedrich von Schmidt designed and built Vienna's CityHall, the most important secular building in the neo-Gothic style in the city, between 1872 and 1883. It isthe official seat of the Mayor and the meeting place ofthe city senate/provincial government and theMunicipal Council/Landtag.
The City Hall is a building of superlatives: The heightof the tower is 97.9 m, plus the so-called "IronRathausmann," which has become a symbol of Vienna.Over 30 million bricks and more than 40,000 cubicmeters of natural stone were used. The Arkadenhof ofCity Hall is one of the biggest inner courtyards inEurope, and Festival Hall is 71 meters long, 20 meterswide and 18.5 meters high. If the fire authorities wereto allow it, 1,500 couples could dance the waltz here atthe same time.
SESSIONSPRE-EVENT PROGRAMS - 24/03/2019
BIO-Europe SpringMarch 25–27, 2019
Messe Wien Exhibition and Congress CenterVienna, Austria
+49 89 2388 756 0 ebdgroup.knect365.com/bioeurope-spring/ conferences@ebdgroup.com
TIME EBD ACADEMY: COURSE 1 EBD ACADEMY: COURSE 2 LEADING BIOTECH MAIN AGENDA NETWORKING
08:00 08:00 - COURSE 1 Continued: The Ne-gotiation Masterclass – ImprovingThe Probability of Success
08:30 - COURSE 2: Product Valuation& Deal Structuring Masterclass
09:00 09:00 - EUROPE CEO
10:00
11:00
12:00
13:00
14:00 14:00 - Registration open
15:00
16:00
17:00
18:00
19:00 19:00 - Welcome Reception
SCHEDULEPRE-EVENT PROGRAMS - 24/03/2019
BIO-Europe SpringMarch 25–27, 2019
Messe Wien Exhibition and Congress CenterVienna, Austria
+49 89 2388 756 0 ebdgroup.knect365.com/bioeurope-spring/ conferences@ebdgroup.com
Registration and Exhibition Open
07:45 - 18:00Main Agenda
Registration Location: Level 0, Foyer A
Exhibition Location: Level 0, Hall A
Please note: The registration desk will be open all day.
Continental Breakfast
07:45 - 09:00Networking
Level 0, Hall A
The perfect pitch: Do you have what it takes towin over investors?
09:00 - 10:00WORKSHOP 1
Level 1, Schubert 4
What you have to say in 30 seconds could mean thedifference between a meeting with an investor and adoor closed in your face. Win a one-to-one meetingwith a leading life science private equity investor.Members of the audience will have 30 seconds to givetheir elevator pitch to a star-studded panel ofseasoned industry investors. The top picks will beselected for a second round that includes two minutesof presentation and/or Q&A time with the judges. First-and second-place winners will receive a full 30-minuteprivate follow-up meeting with the panelist of theirchoice. Judges will receive a written summary of allparticipant pitches and their scores, should they wishto follow up on their own. All are welcome:entrepreneurs, service providers, job seekers,executives and more. Audience preparation notes:Participants will be judged on the quality andeffectiveness of the overall 30-second pitch.Remember, the primary goal of an elevator pitch is tospark interest for a follow-up meeting. Pre-workshopcoaching is available from the moderator (contact:doug@macbiocom.com). Practice, practice, practice!
Participants
Moderator: Douglas MacDougall - Managing Partner,MacDougall Biomedical Communications
Panelist: Jasper Bos - Senior VP and ManagingDirector, M Ventures
Panelist: Roel Bulthuis - Managing Director, INKEFCapital
Panelist: Tim Haines - Managing Partner, Abingworth
Panelist: Christian Jung - Principal, WellingtonPartners Life Sciences
Panelist: Mathieu Pieronne - Investment Manager,Andera Partners
Panelist: Elizabeth Roper - Partner, Epidarex Capital
EBD Academy Buzz Session: Out-licensingpresentations: One is not enough
09:00 - 09:45WORKSHOP 2
Level 1, Schubert 6
Effective communication is one of the most importantfactors associated with successful out-licensingstrategies. It is vital in securing you meetings,conveying your message and outlining your aims.However, too many company executives try (and oftenfail) to secure meetings with prospective licensingpartners, in part because their communications(presentations, meeting request text, emails, etc.) arepoorly designed, poorly written, and rarely customized.
In this buzz session, we will focus on how to craft out-licensing presentations that communicate effectively.Topics covered during this presentation include:• Why more than one presentation is necessary• The number and structure of these out-licensingpresentations• Outlines and examples of each kind ofpresentation...and when to use them• How to craft meeting text that increases yourchances of a meeting at a conference• Why "crosschecking" is critical for starting yourpartnering activities early
Attendees will leave this session with acomprehensive understanding of how out-licensingpresentations should be developed, structured anddelivered. After attending, you will increase yourchances of securing meetings with potential partnersat licensing conferences and beyond.
Participants
Moderator: Carlos N. Velez - Founder and ManagingPartner, Lacerta Bio BD&L
One-to-one meetings
10:00 - 18:30Partnering
Level 0, Hall A
Please note: One-to-one meetings will take place allday depending on your partnering schedule.
Power up partneringONE: Essentials (plusExperienced)
10:00 - 10:45Power up partneringONE
Level 1, Business Suite 1
This session is for delegates new to partnering. Whatcan you expect from partnering, and what do othersexpect from you? Principles around timing, humannature, and partnering etiquette will be applied to thepartneringONE process. The first 30 minutes will giveyou a clear understanding of tactics to generate thebest ROI from partnering, at this and future events.
Those who stay for the full session will also hear thecontent from the Power up: Experienced session. Thesecond half will cover methods for collaborating withcolleagues, saving time, increasing response rates andacceptance rates, based on leveragingpartneringONE’s new power features.
This session is being offered multiple times duringBIO-Europe Spring. Each session is limited to 20people. Please reserve your seat by adding the sessionto your personal agenda. If you can’t attend a session,drop by the partnering help desk with any questions.
Participants
Speaker: Lisa Methley - Senior Director, OnlineStrategy, EBD Group
Welcome and Opening Remarks
10:45 - 11:15Plenary
Level 0 - Lehar 3/4
Participants
Speaker: Pam Putz - Managing Director Europe, EBDGroup
Speaker: Margarete Schramböck - The Minister,Federal Ministry for Digital and Economic Affairs
Speaker: Peter Hanke - Executive City Councillor ofFinance, Business, Digital Innovation and InternationalAffairs, City of Vienna
Speaker: David Thomas - Senior Director, IndustryResearch and Analysis, Biotechnology InnovationOrganization (BIO)
SESSIONSDAY 1 - 25/03/2019
BIO-Europe SpringMarch 25–27, 2019
Messe Wien Exhibition and Congress CenterVienna, Austria
+49 89 2388 756 0 ebdgroup.knect365.com/bioeurope-spring/ conferences@ebdgroup.com
Opening Plenary Discussion: Time to turn theship: Exploring underserved therapeutic areas
11:15 - 12:15Plenary
Level 0, Lehar 3/4
Therapeutic areas outside of oncology, chronicdiseases and CNS spaces tend to be afterthoughts inmany discussions about biotech growth. Underservedtherapeutic areas offer exciting possibilities for futuredevelopment however. These spaces are characterizednot only by small patient populations but also bypatients with poor access to healthcare, bymismatched financial incentives, and high incidence inunfamiliar areas of operation. Often, these areas havesome combination of all four of these features and sodifferent kinds of partnerships and development plansare required. This panel will identify the topunderserved therapeutic areas, explore some of thecurrent efforts to address them and the partnershipsthat are proving to be effective. The panelists willaddress potential areas of future growth and whatneeds to happen in the industry, through policy,research, and funding to bring biotech solutions tounderserved therapeutic areas.
Participants
Moderator: Amy Schulman - Partner, Polaris Partners
Panelist: Michael Crowley - Head, BD for PharmaResearch and Early Development, Roche PharmaPartnering
Panelist: Danielle Friend - Director, Science andRegulatory Affairs, Biotechnology InnovationOrganization (BIO)
Panelist: David Rossow - Founding Partner, StrategicInvestment Fund, Bill & Melinda Gates Foundation
Panelist: Jonathan Wang - VP, Head of BusinessDevelopment, Zai Lab
Luncheon
12:00 - 14:00Networking
Seated Luncheon – Level 0, MallGrab & Go Lunch – Level 0, Hall A
Who wins the seat when investing in Europeanbiotech companies?
13:30 - 14:30Business Development
Level 1, Schubert 1/2
Participants
Moderator: Annegret de Baey-Diepolder - VenturePartner, Life Sciences Department, Seventure Partners
Panelist: Roel Bulthuis - Managing Director, INKEFCapital
Panelist: Laia Crespo - Head of Europe, SanofiVentures
Bruno Montanari - Partner, Seroba Life Sciences
Panelist: Gilles Nobécourt - Partner, Andera Partners
Evolving biopharma landscape in the Asia-Pacific
13:30 - 14:30Spotlight
Level 1, Schubert 4
The 21st century goldrush: With record-breaking dealsin the past two years, partnering and investmentopportunities in the APAC region continue to attractopportunists seeking their fortunes in the biopharmasector. Novel business models are being developed tocreate efficient ways to fund and develop innovativetechnologies and new products at a rate neverwitnessed before. How are companies, investors,accelerators, and other stakeholders working togetherto advance the field? What cross-border opportunitiesare enabling treatments to be developed more quicklyand more broadly? Organizations that are breaking themold and cashing in on the new opportunities sharetheir strategies for success.
Participants
Moderator: Robert Narquizian - Managing Director,ChinaBio® Group
Panelist: Nares Damrongchai - CEO, Thailand Centerof Excellence for Life Sciences
Panelist: Amy Nguyen - Head, Business Development,GreenLight Clinical
Panelist: Rajan Puri - Head, Business DevelopmentNorth America, CMAB Biopharma
Emerging opportunities for investment andpartnering in “metabesity”
13:30 - 14:30Therapeutic
Level 1, Schubert 5
Despite increases in life expectancy over the lastcentury, healthspan—time spent living without chronicdisease—has not significantly increased and remains adriver of immense personal and economic costs.Growing evidence has linked common metabolic rootsto the aging process and multiple chronic diseases,collectively referred to as metabesity. Presently,targeting metabesity indications requires first pursuingestablished gateway indications—T2DM, obesity and,more recently, NASH, all of which come with their owndevelopment, regulatory and market accesschallenges. Nevertheless, a new wave of biotechcompanies with promising assets is targetinghealthspan and other metabesity indications. A widevariety of strategies are being used: pursuing initialorphan indications, novel efficacy composites, andadvanced computational tools, including artificialintelligence. Join our panel as we discuss prospectsand opportunities for investing and partnering inmetabesity programs.
Participants
Moderator: Danielle M. Marra - Associate Principal,Cello Health BioConsulting
Panelist: Sree Kant - Head, Business Development,Life Biosciences
Panelist: Tomas Landh - Innovation Sourcing VP,Senior Principal Scientist, Novo Nordisk
Panelist: Thomas Seoh - President and CEO, Kinexum
SESSIONSDAY 1 - 25/03/2019
BIO-Europe SpringMarch 25–27, 2019
Messe Wien Exhibition and Congress CenterVienna, Austria
+49 89 2388 756 0 ebdgroup.knect365.com/bioeurope-spring/ conferences@ebdgroup.com
Pharma Company Presentations
13:30 - 17:00Company Presentations
Level 0, Lehar 3/4
14:00–14:15 – Bristol-Myers Squibb – Paul Biondi,Senior Vice President, Strategy and BusinessDevelopment
14:15–14:30 – Roche Pharma Partnering – J.C.Lopez, Business Development Associate
14:30–14:45 – Bayer – Christoph Geserick, Director,Early Licensing & Transactions
14:45–15:00 – Johnson & Johnson Innovation –Guenter Huhle, Head of JLABS EMEA
15:00–15:15 – AbbVie – Joachim Vogt, DirectorSearch & Evaluation Western Europe
15:15–15:30 – Sanofi – Olivier Reinhard, Head ofBusiness Development & Licensing Transactions –China & Emerging Markets
15:30–15:45 – MSD – Phil L’Huillier, Head of BusinessDevelopment, Europe & Middle East
15:45–16:00 – Amgen – Samantha Palmer, Director,Business Development
16:00–16:15 – Eli Lilly and Company – JohnstonErwin, Vice President, Corporate BusinessDevelopment
16:15–16:30 – Boehringer Ingelheim – Dr. GuidoBoehmelt, Director External Innovation, ResearchBeyond Borders and Silke Hobbie, Global Head ofRespiratory Business Development & Licensing
16:30–16:45 – Merck – Philippe Lopes-Fernandes,SVP, Global Head of Business Development & AllianceManagement
16:45–17:00 – Servier – Didier Landais, Global Headof Licensing
Art of multitrack deal: Keys to maximizing thevalue of your company
14:45 - 15:45Business Development
Level 1, Schubert 1/2
Pursuing multiple deal options in parallel will createthe kind of competitive tension that will enable acompany to achieve the fullest value for an asset orthe company itself, whether the end result of thatprocess is an asset sale, global or regionalpartnership, new round of investment, or M&A. Learnwhich companies can benefit from a multi-track, howto time the components, and how to position for apositive outcome.
Participants
Moderator: Lubor Gaal - Senior VP, Head of Europe,Locust Walk
Panelist: Hubert Birner - Managing Partner, TVMCapital Life Science
Panelist: Timothy Herpin - Chief Business Officer,Caribou Biosciences
Panelist: Jennifer Laird - VP, Search and Evaluation,Neuroscience, Eli Lilly and Company
Panelist: Øystein Soug - CEO, Targovax
Product development and market access: Thetransformational changes within China
14:45 - 15:45Spotlight
Level 1, Schubert 4
The Asia Pacific region represents more than 50% ofthe world’s population, one that needs to address itsproliferation of common Western chronic diseases, aquickly expanding aging society, and health conditionsunique to the area. This presents significantopportunities for companies that are able to meet theneeds of these diverse patient groups. We will discusshow China’s new economy biotechs are able toleverage the increasingly supportive regulatoryenvironment, the large and hungry investor base, andthe maturing ecosystem? What strategies are beingused to gain access to this market that simultaneouslyrepresents developed and emerging markets? How arethe players mastering regional and global markets?Leaders in this field share their insights on the bestways to navigate this evolving landscape.
Participants
Moderator: Debra Yu - Managing Director, ChinaRenaissance
Panelist: Jun Bao - President and CEO, IMPACTTherapeutics
Panelist: Jay Mei - Chairman and CEO, Antengene
Panelist: John Xu - CEO and Cofounder, JemincareTherapeutics Corp
Panelist: Jonathan Zhao - Executive Chairman,Transcenta
What’s NEXT in NASH?
14:45 - 15:45Therapeutic
Level 1, Schubert 5
NASH is fast growing into a global epidemic and isgoing to become the leading cause of liver transplantswith the number of transplantable organs nowhereclose to meeting this future demand. Will the industrysucceed to deliver treatments for an emerging NASHpandemic in time? Europe, the US and Asia havebrought forth a number of players in the space withabout 195 treatments in the pipeline but currentlythere are no approved therapies and the lion's share ofprograms target the early stages of NASH. The marketis pegged to hit $25 billion by 2026 for the truewinners of this race—first in class and best in classapproaches—to take. This panel will look at what isnext to come in NASH and what will truly make adifference in this devastating illness in the long run.
Participants
Moderator: Mario Brkulj - VP, MacDougall BiomedicalCommunications
Panelist: Manuel Baader - Deputy Head of GlobalBD&L, CardioMetabolic Diseases, BoehringerIngelheim
Panelist: Marco Boorsma - General Partner, Forbion
Panelist: Pascale Jordan - Director, BusinessDevelopment, External Evaluation, PrometheraBiosciences
Panelist: Tuan Huy Nguyen - Chairman and ChiefScientific Officer, GoLiver Therapeutics
Towards the splendid city: Creating world-leading biotech companies in Europe
16:00 - 17:00Business Development
Level 1, Schubert 1/2
Participants
Moderator: Vanela Bushi - Director, Strategy andTransactions, Syneos Health Consulting
Panelist: Regina Hodits - General Partner, WellingtonPartners Life Sciences
Panelist: Peter B. Leone - Chief Business Officer,Bicycle Therapeutics
Panelist: Nerida Scott - VP, New Ventures andTransactions, Johnson & Johnson Innovation
Panelist: Jeff Wasserstein - Managing Director,Greenhill & Co.
SESSIONSDAY 1 - 25/03/2019
BIO-Europe SpringMarch 25–27, 2019
Messe Wien Exhibition and Congress CenterVienna, Austria
+49 89 2388 756 0 ebdgroup.knect365.com/bioeurope-spring/ conferences@ebdgroup.com
Commercial opportunities and challenges incell and gene: The keys to success
16:00 - 17:00Spotlight
Level 1, Schubert 4
As clinical advances continue to be made and newtreatments and potential cures are being developed,how can we ensure that patients will have access tothese life-changing products? How are companiesworking together with government agencies toaddress regulatory, market access, and pricing issues?How are new guidelines such as RMAT designationfacilitating the approval of new drugs? What types ofnovel pricing models are being developed to addressthe high costs of these products? Industry experts willdiscuss the new paths available for bringing theseadvanced therapies to market.
Participants
Moderator: Paolo Morgese - Director, EU MarketAccess and Member Relations, Alliance forRegenerative Medicine (ARM)
Panelist: Jeff Abbey - CEO, Novadip Biosciences
Panelist: Becky Buzzeo - Senior Director, GlobalBusiness Development - Biologics, Thermo FisherScientific, Pharma Services
Panelist: Roman Necina - Chief StrategistPharmaceutical Sciences, Takeda
Panelist: Peter Nell - VP, Strategy and BusinessDevelopment, Casebia Therapeutics
Oncology positioning and partneringstrategies: IO, non-IO, and everything inbetween!
16:00 - 17:00Therapeutic
Level 1, Schubert 5
The clinical and commercial impact of anticancerimmunotherapies cannot be overstated: Durableremissions in subsets of end-stage patients withimmune checkpoint inhibitors and CAR-T therapies,and the ensuing influx of investment and partneringactivity, have been astounding. With the dust startingto settle, however, it is becoming apparent that thepath towards building upon such early IO successeswill be anything but straightforward. In the meantime,more traditional “non-IO” approaches continue togenerate therapeutic responses and revenues. Indeed,the recent successes of tumor-agnostic “basket” trialsserve as powerful reminders of the potential fortargeted therapies in the modern age. Pharmas arechoosing different lanes where they believe they canwin, with some shunning IO altogether while otherschoosing to go all-in with CAR-Ts, for example. Suchstrategies from bellwethers have an impact on howbiotech and investors approach their own decisions,both in terms of where to invest and how to positionthemselves for success. Join us as we explore thetrade-offs and implications of different positioning andpartnering strategies being employed by pharma,biotech, and investors in what promises to be animportant and exciting discussion for anyone lookingto win in the massive but incredibly crowded oncologymarket.
Participants
Moderator: Joel Sandler - Associate Principal, CelloHealth BioConsulting
Panelist: Soren Bregenholt - CBO, IO Biotech
Panelist: Emilio Erazo-Fischer - Deputy Head ofOncology BD&L, Boehringer Ingelheim
Panelist: Serge Sagodira - Head of Transactions,Debiopharm
BREAK AND BREATHE
16:05 - 16:25Extra Activity
Level 1, Schubert 3
EXTRA ACTIVITY: BREAK AND BREATHEEnhance your conference experience by using simplebreathing techniques, movement and light stretches inorder to charge your body and mind for better decisionmaking and more energy throughout the day.
The breath is a source of life. By practicing specialbreathing techniques, we can fight diseases, stimulatethe endocrine and autonomic nervous systems andpurify the blood. These breathing techniques aredesigned to make the body fit and to handle stress ineveryday life.
Open to all. No prerequisites required. Standing andseated (chair) positions only.
Power up partneringONE: Experienced
16:30 - 17:00Power up partneringONE
Level 1, Business Suite 1
This session is for delegates familiar with partneringwho want to up their game. Best practices forcollaborating with colleagues, saving time, increasingresponse rates and acceptance rates will be discussedin terms of partneringONE, including new powerfeatures to support optimal partnering etiquette. Comeaway from the session with a clear understanding ofhow partneringONE can support your company tomaximize ROI from partnering, at this and futureevents.
This session is being offered multiple times duringBIO-Europe Spring. Each session is limited to 20people. Please reserve your seat by adding the sessionto your personal agenda. If you can’t attend a session,drop by the partnering help desk with any questions.
Participants
Speaker: Lisa Methley - Senior Director, OnlineStrategy, EBD Group
SESSIONSDAY 1 - 25/03/2019
BIO-Europe SpringMarch 25–27, 2019
Messe Wien Exhibition and Congress CenterVienna, Austria
+49 89 2388 756 0 ebdgroup.knect365.com/bioeurope-spring/ conferences@ebdgroup.com
BREAK AND BREATHE
16:35 - 16:55Extra Activity
Level 1, Schubert 3
EXTRA ACTIVITY: BREAK AND BREATHEEnhance your conference experience by using simplebreathing techniques, movement and light stretches inorder to charge your body and mind for better decisionmaking and more energy throughout the day.
The breath is a source of life. By practicing specialbreathing techniques, we can fight diseases, stimulatethe endocrine and autonomic nervous systems andpurify the blood. These breathing techniques aredesigned to make the body fit and to handle stress ineveryday life.
Open to all. No prerequisites required. Standing andseated (chair) positions only.
Champagne reception
17:45 - 18:45Networking
Level 0, Hall A
EBD Group, Booth #61
Evening Networking Reception
19:00 - 22:00Networking
LOCATION:HOFBURG ViennaHeldenplatz 11010 Vienna
The Hofburg Vienna was the former winter residenceof the Habsburgs, and boasts 54 staircases, 19courtyards and 2,600 different rooms. The splendidCeremonial Hall, designed as a throne room forEmperor Franz II/I, is a symphony of shapes andcolors, along with the stunning Grand Staircase thatleads to the conference halls. The ceiling paintings arealso a breathtaking sight.
Ever since the Congress of Vienna in 1814/15, theHofburg has been a regular venue for prominentinternational meetings, like the legendary encounterbetween the Presidents of the USSR and the UnitedStates, Nikita Khrushchev and John F. Kennedy, in1961, or the signing of the SALT II Treaty by USPresident Jimmy Carter and Soviet President LeonidBrezhnev in 1979, or more recently the visit of PopeBenedict XVI in 2007. Hofburg Vienna can be calledEurope’s first address for international meetings.
17:00–19:00 Shuttle buses depart from theconference center to partner hotels.18:30–19:15 Shuttle buses depart from theconference center to the evening event.21:00–22:00 Shuttle buses depart from the eveningevent to all conference hotels.
SESSIONSDAY 1 - 25/03/2019
BIO-Europe SpringMarch 25–27, 2019
Messe Wien Exhibition and Congress CenterVienna, Austria
+49 89 2388 756 0 ebdgroup.knect365.com/bioeurope-spring/ conferences@ebdgroup.com
TIME BUSINESS DE-VELOPMENT
COMPANYPRESENTA-TIONS
EXTRA ACTIV-ITY
MAIN AGEN-DA
NETWORKING PARTNERING PLENARY POWER UPPARTNER-INGONE
SPOTLIGHT THERAPEUTIC WORKSHOP 1 WORKSHOP 2
07:00 07:45 - Regis-tration andExhibitionOpen
07:45 - Conti-nental Break-fast
08:00
09:00 09:00 - Theperfect pitch:Do you havewhat it takesto win over in-vestors?
09:00 - EBDAcademyBuzz Session:Out-licensingpresenta-tions: One isnot enough
10:00 10:00 - One-to-one meet-ings
10:45 - Wel-come andOpening Re-marks
10:00 - Powerup partner-ingONE: Es-sentials (plusExperienced)
11:00 11:15 - Open-ing PlenaryDiscussion:Time to turnthe ship: Ex-ploring under-served thera-peutic areas
12:00 12:00 - Lun-cheon
SCHEDULEDAY 1 - 25/03/2019
BIO-Europe SpringMarch 25–27, 2019
Messe Wien Exhibition and Congress CenterVienna, Austria
+49 89 2388 756 0 ebdgroup.knect365.com/bioeurope-spring/ conferences@ebdgroup.com
TIME BUSINESS DE-VELOPMENT
COMPANYPRESENTA-TIONS
EXTRA ACTIV-ITY
MAIN AGEN-DA
NETWORKING PARTNERING PLENARY POWER UPPARTNER-INGONE
SPOTLIGHT THERAPEUTIC WORKSHOP 1 WORKSHOP 2
13:00 13:30 - Whowins the seatwhen invest-ing in Euro-pean biotechcompanies?
13:30 - Phar-ma CompanyPresentations
13:30 - Evolv-ing biophar-ma land-scape in theAsia-Pacific
13:30 -Emerging op-portunitiesfor invest-ment andpartnering in“metabesity”
14:00 14:45 - Art ofmultitrackdeal: Keys tomaximizingthe value ofyour compa-ny
14:45 - Prod-uct develop-ment andmarket ac-cess: Thetransforma-tionalchanges with-in China
14:45 -What’s NEXTin NASH?
15:00
16:00 16:00 - To-wards thesplendid city:Creatingworld-leadingbiotech com-panies in Eu-rope
16:05 -BREAK ANDBREATHE
16:35 -BREAK ANDBREATHE
16:30 - Powerup partner-ingONE: Ex-perienced
16:00 - Com-mercial op-portunitiesand chal-lenges in celland gene:The keys tosuccess
16:00 - Oncol-ogy position-ing and part-nering strate-gies: IO, non-IO, and every-thing in be-tween!
17:00 17:45 -Champagnereception
SCHEDULEDAY 1 - 25/03/2019
BIO-Europe SpringMarch 25–27, 2019
Messe Wien Exhibition and Congress CenterVienna, Austria
+49 89 2388 756 0 ebdgroup.knect365.com/bioeurope-spring/ conferences@ebdgroup.com
TIME BUSINESS DE-VELOPMENT
COMPANYPRESENTA-TIONS
EXTRA ACTIV-ITY
MAIN AGEN-DA
NETWORKING PARTNERING PLENARY POWER UPPARTNER-INGONE
SPOTLIGHT THERAPEUTIC WORKSHOP 1 WORKSHOP 2
18:00
19:00 19:00 -Evening Net-working Re-ception
SCHEDULEDAY 1 - 25/03/2019
BIO-Europe SpringMarch 25–27, 2019
Messe Wien Exhibition and Congress CenterVienna, Austria
+49 89 2388 756 0 ebdgroup.knect365.com/bioeurope-spring/ conferences@ebdgroup.com
RISE AND RUN
06:30 - 07:30Extra Activity
Meeting at:Vienna Marriott Hotel – Main LobbyParkring 12a1010 Vienna
Ease yourself into a busy second day at BIO-EuropeSpring with an early-morning run along some ofVienna's famous sites. The pace will be comfortableenough to chat, and runners of all levels are welcome.Bring hat and gloves for a cold morning, but we willcancel for very inclement weather.
Registration and Exhibition Open
07:45 - 18:00Main Agenda
Registration Location: Level 0, Foyer A
Exhibition Location: Level 0, Hall A
Please note: The registration desk will be open all day.
Continental Breakfast
07:45 - 09:00Networking
Level 0, Hall A
One-to-one meetings
08:00 - 18:30Partnering
Level 0, Hall A
Please note: One-to-one meetings will take place allday depending on your partnering schedule.
New partnership and investment models
09:00 - 10:00Startup Spotlight
Level 1, Schubert 1/2
With the entrance of new partners and investors,startups are not limited to seeking out VC funding todrive growth. Startups are advancing their research bypartnering with patient advocacy groups, academia,innovation hubs, and other stakeholders. Instead oftraditional funding, new models where partners areproviding infrastructure, preclinical research supportfor stake in company, or expertise to offset costs aregaining momentum. Learn about the latest modelsand perhaps meet your match.
Participants
Moderator: Lucie Ellis - Executive Editor, In Vivo,Informa Pharma Intelligence
Panelist: Gabriela Apiou - Director of StrategicAlliances, Mass General Hospital Research Institute
Panelist: Borja Carsi - Investment Officer, EuropeanInvestment Bank
Panelist: Michael Johnson - VP Transactions,Immunology, Eli Lilly and Company
Panelist: Johannes Sarx - Managing Director,LISAvienna
Panelist: Marek Tyl - CEO and Founder, GlobalInnovation Forum
Company Presentations
09:00 - 12:00Company Presentations
Level 1, Schubert 4 & 5
Startup Spotlight Company Presentations
10:00 - 12:15Startup Spotlight
Level 1, Schubert 1/2
Presenting Companies:
Elypta AB
Medibiofarma
Ablevia biotech GmbH
Isanans Pharma
Respirogen, Inc.
Stimunity
ResoTher Pharma ApS
Stratify Genomics
GlakoLens
EsoCap AG
Aelian Biotechnology
ImStar Therapeutics
Participants
Coach: Julia Belaya - Director, Health and StartupCreasphere, Plug & Play
Coach: Tim Luker - VP, Emerging Technology andInnovation, Corporate Business Development, Eli Lilly &Company
Coach: Stefan Luzi - Partner, Gilde Healthcare
Coach: Daniel Parera - Executive-in-residence, TVMCapital Life Science
BREAK AND BREATHE
11:05 - 11:25Extra Activity
Level 1, Schubert 3
EXTRA ACTIVITY: BREAK AND BREATHEEnhance your conference experience by using simplebreathing techniques, movement and light stretches inorder to charge your body and mind for better decisionmaking and more energy throughout the day.
The breath is a source of life. By practicing specialbreathing techniques, we can fight diseases, stimulatethe endocrine and autonomic nervous systems andpurify the blood. These breathing techniques aredesigned to make the body fit and to handle stress ineveryday life.
Open to all. No prerequisites required. Standing andseated (chair) positions only.
SESSIONSDAY 2 - 26/03/2019
BIO-Europe SpringMarch 25–27, 2019
Messe Wien Exhibition and Congress CenterVienna, Austria
+49 89 2388 756 0 ebdgroup.knect365.com/bioeurope-spring/ conferences@ebdgroup.com
BREAK AND BREATHE
11:35 - 11:55Extra Activity
Level 1, Schubert 3
EXTRA ACTIVITY: BREAK AND BREATHEEnhance your conference experience by using simplebreathing techniques, movement and light stretches inorder to charge your body and mind for better decisionmaking and more energy throughout the day.
The breath is a source of life. By practicing specialbreathing techniques, we can fight diseases, stimulatethe endocrine and autonomic nervous systems andpurify the blood. These breathing techniques aredesigned to make the body fit and to handle stress ineveryday life.
Open to all. No prerequisites required. Standing andseated (chair) positions only.
Luncheon
12:00 - 14:00Networking
Seated Luncheon – Level 0, MallGrab & Go Lunch – Level 0, Hall A
What a partner wants
12:15 - 13:00Startup Spotlight
Level 1, Schubert 1/2
Prior to the pitch, a startup must understand whatpotential partners and investors are looking for in theircompany. Why is your science relevant to a diseaseand how will you demonstrate your product claims?Who in your team has the experience to move aproduct through development and understand whenyou need outside help? What elements are obviousand what should companies be thinking about that’scurrently not on their radar?
Participants
Moderator: Giovanni Mariggi - Partner, Medicxi
Panelist: Julia Belaya - Director, Health and StartupCreasphere, Plug & Play
Panelist: Tim Haines - Managing Partner, Abingworth
Panelist: Julien Michaux - Managing Director, NorgineVentures
Panelist: Katja Rosenkranz - Partner, V-Bio Ventures
Panelist: Paul-Peter Tak - Venture Partner, FlagshipPioneering
Plenary Session: A day in the life ofexperienced dealmakers
13:00 - 14:00Plenary
Level 0, Lehar 3/4
Participants
Moderator: Evonne Sepsis - Founder and ManagingDirector, ESC Advisors
Moderator: Anton Gueth - Managing Director,EVOLUTION Life Science Partners
Panelist: Paul Biondi - Senior VP, Strategy andBusiness Development, Bristol-Myers Squibb
Panelist: Constantine Chinoporos - CBO, BostonPharmaceuticals
Panelist: Philippe Lopes-Fernandes - Senior VP, GlobalHead, Business Development and AllianceManagement, MERCK
Panelist: Chris Vlahos - Global Head, ExternalInnovation, Rare Diseases and Neuroscience, Ipsen
Company Presentations
14:00 - 17:00Company Presentations
Level 1, Schubert 4 & 5
Case study: Following the clients' demand:Expanding from Europe to the US
14:00 - 15:00Additional Program
Level 1, Schubert 6
Having a global footprint paves the way to greaterbenefits, allowing for better coordination of resourcesand often surprising benefits for partners all along theproduction and supply chain. This session willexamine international case studies to show how thefollow-on effects of a new geographical base canimpact production, supply, strategy, and partnerrelationships. Panelists will also examine the factorsthat need to be considered before, during and after thetransaction in order to realize successful integration.
Participants
Moderator: Johannes Roebers - Founder and CEO,Cilatus Biopharma Consulting AG
Panelist: Klaus Maleck - CEO, TETEC AG
Panelist: Bernd Muehlenweg - CBO, Nanobiotix
Panelist: Konstantin Petropoulos - VP, BD, Marketingand Sales, Leukocare AG
Panelist: Federico Pollano - Senior VP, BusinessDevelopment, Rentschler Biopharma SE
Panelist: Marianne Spaene - Executive VP, GlobalBusiness Development, Marketing and Sales, SiegfriedAG
Pushing the boundaries: Digital technologiestransforming the biopharma value chain
14:15 - 15:45Spotlight
Level 1, Schubert 1/2
There is little doubt that digital technology istransforming the entire biopharma value chain.Biopharma companies are using data analytics, bigdata, genomics, artificial intelligence and other digitaltechnologies to bolster research and development,facilitate regulatory approval, speed time to market,find new ways to connect with patients andconsumers, and measure the safety and effectivenessof therapies. This panel will dive into the opportunitiesand challenges that digital technologies present,exploring such questions as: What are the successfuluse cases for digital technologies in biopharma? Whatare the biggest challenges and risks? How can digitaltechnologies be applied to the biopharma sector?
Participants
Moderator: Martin Pöhlchen - Senior Partner, AliraHealth
Panelist: Etienne Bendjebbar - Business DevelopmentAssociate, OWKIN
Panelist: Sarah Hogan - Partner, McDermott Will &Emery LLP
Panelist: Nora Khaldi - Founder and CSO, Nuritas
Panelist: Bernd Nosse - Global Head BD<echnologies, Boehringer Ingelheim InternationalGmbH
Panelist: Andreas Posch - Managing Director and CEO,Ares Genetics
SESSIONSDAY 2 - 26/03/2019
BIO-Europe SpringMarch 25–27, 2019
Messe Wien Exhibition and Congress CenterVienna, Austria
+49 89 2388 756 0 ebdgroup.knect365.com/bioeurope-spring/ conferences@ebdgroup.com
Power up partneringONE: Essentials (plusExperienced)
16:00 - 17:00Power up partneringONE
Level 1, Business Suite 1
This session is for delegates new to partnering. Whatcan you expect from partnering, and what do othersexpect from you? Principles around timing, humannature, and partnering etiquette will be applied to thepartneringONE process. The first 30 minutes will giveyou a clear understanding of tactics to generate thebest ROI from partnering, at this and future events.
Those who stay for the full session will also hear thecontent from the Power up: Experienced session. Thesecond half will cover methods for collaborating withcolleagues, saving time, increasing response rates andacceptance rates, based on leveragingpartneringONE’s new power features.
This session is being offered multiple times duringBIO-Europe Spring. Each session is limited to 20people. Please reserve your seat by adding the sessionto your personal agenda. If you can’t attend a session,drop by the partnering help desk with any questions.
Participants
Speaker: Lisa Methley - Senior Director, OnlineStrategy, EBD Group
BREAK AND BREATHE
16:05 - 16:25Extra Activity
Level 1, Schubert 3
EXTRA ACTIVITY: BREAK AND BREATHEEnhance your conference experience by using simplebreathing techniques, movement and light stretches inorder to charge your body and mind for better decisionmaking and more energy throughout the day.
The breath is a source of life. By practicing specialbreathing techniques, we can fight diseases, stimulatethe endocrine and autonomic nervous systems andpurify the blood. These breathing techniques aredesigned to make the body fit and to handle stress ineveryday life.
Open to all. No prerequisites required. Standing andseated (chair) positions only.
BREAK AND BREATHE
16:35 - 16:55Extra Activity
Level 1, Schubert 3
EXTRA ACTIVITY: BREAK AND BREATHEEnhance your conference experience by using simplebreathing techniques, movement and light stretches inorder to charge your body and mind for better decisionmaking and more energy throughout the day.
The breath is a source of life. By practicing specialbreathing techniques, we can fight diseases, stimulatethe endocrine and autonomic nervous systems andpurify the blood. These breathing techniques aredesigned to make the body fit and to handle stress ineveryday life.
Open to all. No prerequisites required. Standing andseated (chair) positions only.
Exhibit Hall Hospitality Receptions
17:45 - 18:45Networking
Evening Networking Reception
19:00 - 23:00Networking
LOCATION:GösserhalleLaxenburgerstrasse 2B1100 Vienna
Over 120 years old, Gösserhalle once served as awarehouse for Gösser Bier (from Styria), which wasdelivered in wooden barrels to taverns around Viennaby horse-drawn carriages. The charming venue withsix architecturally unique spaces is a journey into OldWord ambience in the center of Vienna.
17:00–19:00 Shuttle buses depart from theconference center to partner hotels.18:30–19:15 Shuttle buses depart from theconference center to the evening event.21:30–23:00 Shuttle buses depart from the eveningevent to all conference hotels.
SESSIONSDAY 2 - 26/03/2019
BIO-Europe SpringMarch 25–27, 2019
Messe Wien Exhibition and Congress CenterVienna, Austria
+49 89 2388 756 0 ebdgroup.knect365.com/bioeurope-spring/ conferences@ebdgroup.com
TIME ADDITIONALPROGRAM
COMPANY PRE-SENTATIONS
EXTRA ACTIVITY MAIN AGENDA NETWORKING PARTNERING PLENARY POWER UP PART-NERINGONE
SPOTLIGHT STARTUP SPOT-LIGHT
06:00 06:30 - RISE ANDRUN
07:00 07:45 - Registra-tion and Exhibi-tion Open
07:45 - Continen-tal Breakfast
08:00 08:00 - One-to-one meetings
09:00 09:00 - CompanyPresentations
09:00 - New part-nership and in-vestment models
10:00 10:00 - StartupSpotlight Compa-ny Presentations
11:00 11:05 - BREAKAND BREATHE
11:35 - BREAKAND BREATHE
12:00 12:00 - Luncheon 12:15 - What apartner wants
13:00 13:00 - PlenarySession: A day inthe life of experi-enced dealmak-ers
SCHEDULEDAY 2 - 26/03/2019
BIO-Europe SpringMarch 25–27, 2019
Messe Wien Exhibition and Congress CenterVienna, Austria
+49 89 2388 756 0 ebdgroup.knect365.com/bioeurope-spring/ conferences@ebdgroup.com
TIME ADDITIONALPROGRAM
COMPANY PRE-SENTATIONS
EXTRA ACTIVITY MAIN AGENDA NETWORKING PARTNERING PLENARY POWER UP PART-NERINGONE
SPOTLIGHT STARTUP SPOT-LIGHT
14:00 14:00 - Casestudy: Followingthe clients' de-mand: Expandingfrom Europe tothe US
14:00 - CompanyPresentations
14:15 - Pushingthe boundaries:Digital technolo-gies transform-ing the biophar-ma value chain
15:00
16:00 16:05 - BREAKAND BREATHE
16:35 - BREAKAND BREATHE
16:00 - Power uppartneringONE:Essentials (plusExperienced)
17:00 17:45 - ExhibitHall HospitalityReceptions
18:00
19:00 19:00 - EveningNetworking Re-ception
SCHEDULEDAY 2 - 26/03/2019
BIO-Europe SpringMarch 25–27, 2019
Messe Wien Exhibition and Congress CenterVienna, Austria
+49 89 2388 756 0 ebdgroup.knect365.com/bioeurope-spring/ conferences@ebdgroup.com
Registration and Exhibition Open
07:45 - 16:30Main Agenda
Registration Location: Level 0, Foyer A
Exhibition Location: Level 0, Hall A
Please note: The registration desk will be open all day.
Continental Breakfast
07:45 - 09:00Networking
Level 0, Hall A
One-to-one meetings
08:00 - 17:00Partnering
Level 0, Hall A
Gut instincts: Latest partnerships andcollaboration models in microbiome
09:00 - 10:00Spotlight on Microbiome
Level 1 Schubert 6
Gain insights to the different approaches and latestcollaboration models taking shape in the Microbiomearena.
Participants
Moderator: Philip Hemme - CEO, Labiotech.eu
Panelist: Michel de Baar - Executive Director, BusinessDevelopment, Europe, MSD
Panelist: Isabelle de Cremoux - CEO and ManagingPartner, Seventure Partners
Panelist: Georges Rawadi - CEO, LNC Therapeutics
HTA session/IGES: How does Europe set theprice for a new drug?
09:00 - 10:00Additional Program
Level 1, Business Suite 2
There is only one central approval for innovative drugsin Europe, but each European member state has itsown pricing system. Per capita income, social securitysystems and medical guidelines vary from state tostate. In this interactive workshop, we would like toexplain how the health economic value of innovativemedicines is assessed, how prices are determined andhow small and mid-sized companies deal best with theEuropean regulations and the different organizationsat stake. Smaller and mid-sized biopharma companiesare invited to join and discuss with the experts.
Participants
Moderator: Peter Braunhofer - Senior Expert, Valueand Access Europe, IGES Group, Basel
Panelist: Patrick Schneider - Senior Expert, Pricingand Market Access Switzerland, Hölzle, Buri & Partner,Zug
Panelist: Claudia Wild - Director, Ludwig BoltzmannInstitute for Health Technology Assessment, Vienna
Company Presentations
09:30 - 12:00Company Presentations
Level 1, Schubert 4 & 5
Power up partneringONE: Essentials (plusExperienced)
09:30 - 10:30Power up partneringONE
Level 1, Business Suite 1
This session is for delegates new to partnering. Whatcan you expect from partnering, and what do othersexpect from you? Principles around timing, humannature, and partnering etiquette will be applied to thepartneringONE process. The first 30 minutes will giveyou a clear understanding of tactics to generate thebest ROI from partnering, at this and future events.
Those who stay for the full session will also hear thecontent from the Power up: Experienced session. Thesecond half will cover methods for collaborating withcolleagues, saving time, increasing response rates andacceptance rates, based on leveragingpartneringONE’s new power features.
This session is being offered multiple times duringBIO-Europe Spring. Each session is limited to 20people. Please reserve your seat by adding the sessionto your personal agenda. If you can’t attend a session,drop by the partnering help desk with any questions.
Participants
Speaker: Lisa Methley - Senior Director, OnlineStrategy, EBD Group
Pre-Conference Workshop: Navigating theregulatory landscape for microbiometherapeutics
11:00 - 12:00Additional Program
Part 1: What are the need-to-know regulatory,nonclinical and clinical-specific characteristics ofmicrobiome products?
Speakers:
Peri Aghadiuno – EU Medical Director, VoisinConsulting Life Sciences
Clara Desvignes – Regulatory Scientist, VoisinConsulting Life Sciences
Cécile Rousseau – Director, Voisin Consulting LifeSciences
This workshop is a pre-event taste of the MicrobiomeTherapeutics conference which takes place March28–29 here in Vienna, connecting the dots fromdiscovery to commercialization. See here for fullworkshop details for the two-day agenda Thursdayand Friday, March 28–29.
SESSIONSDAY 3 - 27/03/2019
BIO-Europe SpringMarch 25–27, 2019
Messe Wien Exhibition and Congress CenterVienna, Austria
+49 89 2388 756 0 ebdgroup.knect365.com/bioeurope-spring/ conferences@ebdgroup.com
BREAK AND BREATHE
11:05 - 11:25Extra Activity
Level 1, Schubert 3
Enhance your conference experience by using simplebreathing techniques, movement and light stretches inorder to charge your body and mind for better decisionmaking and more energy throughout the day. Thebreath is a source of life. By practicing specialbreathing techniques, we can fight diseases, stimulatethe endocrine and autonomic nervous systems andpurify the blood. These breathing techniques aredesigned to make the body fit and to handle stress ineveryday life. Open to all. No prerequisites required.Standing and seated (chair) positions only.
Power up partneringONE: Experienced
11:30 - 12:00Power up partneringONE
Level 1, Business Suite 1
This session is for delegates familiar with partneringwho want to up their game. Best practices forcollaborating with colleagues, saving time, increasingresponse rates and acceptance rates will be discussedin terms of partneringONE, including new powerfeatures to support optimal partnering etiquette. Comeaway from the session with a clear understanding ofhow partneringONE can support your company tomaximize ROI from partnering, at this and futureevents.
This session is being offered multiple times duringBIO-Europe Spring. Each session is limited to 20people. Please reserve your seat by adding the sessionto your personal agenda. Or drop by the Power Zone,beside the partnering help desk, with any questions.
Participants
Speaker: Lisa Methley - Senior Director, OnlineStrategy, EBD Group
BREAK AND BREATHE
11:35 - 11:55Extra Activity
Level 1, Schubert 3
Enhance your conference experience by using simplebreathing techniques, movement and light stretches inorder to charge your body and mind for better decisionmaking and more energy throughout the day. Thebreath is a source of life. By practicing specialbreathing techniques, we can fight diseases, stimulatethe endocrine and autonomic nervous systems andpurify the blood. These breathing techniques aredesigned to make the body fit and to handle stress ineveryday life. Open to all. No prerequisites required.Standing and seated (chair) positions only.
Luncheon
12:00 - 14:00Networking
Seated Luncheon – Level 0, MallGrab & Go Lunch – Level 0, Hall A
Pre-Conference Workshop: Navigating theregulatory landscape for microbiometherapeutics
13:00 - 16:00Additional Program
Part 2: What are the need-to-know regulatory,nonclinical and clinical-specific characteristics ofmicrobiome products?
Speakers:
Peri Aghadiuno – EU Medical Director, VoisinConsulting Life Sciences
Clara Desvignes – Regulatory Scientist, VoisinConsulting Life Sciences
Cécile Rousseau – Director, Voisin Consulting LifeSciences
This workshop is a pre-event taste of the MicrobiomeTherapeutics conference which takes place March28–29 here in Vienna, connecting the dots fromdiscovery to commercialization. See here for fullworkshop details for the two-day agenda Thursdayand Friday, March 28–29.
Session 1: The 5 most important upcomingtrends in European biotech
14:00 - 14:45Labiotech Refresh event
Level 1, Schubert 1/2
The CEO of Evotec will discuss his views on theupcoming trends and challenges facing Europeanbiotech in the next few years. This will be followed by adiscussion with Labiotech CEO Philip Hemme.
Participants
Moderator: Philip Hemme - CEO, Labiotech.eu
Speaker: Werner Lanthaler - CEO, Evotec
Buses to airport
14:00 - 18:00Transportation to Airport
Shuttle buses depart from the conference center toVienna Airport
Session 2: What's lying ahead for Europeanbiotech in 2019 and beyond
14:50 - 15:35Labiotech Refresh event
Level 1, Schubert 1/2
Helen Albert, Editor-in-Chief of Labiotech, will discussthe more immediate future of European biotech andwhat the hot topics in 2019 and beyond will be with apanel of three great speakers from both the scientificand the investment side of the industry.
Participants
Moderator: Helen Albert - Editor-in-Chief, Labiotech.eu
Panelist: Alexander Belcredi - CEO, PhagoMed
Panelist: Vanessa King - CEO, Virion Biotherapeutics
Panelist: Erich Tauber - CEO, Themis Bioscience
Baba (Goodbye) Vienna – Bienvenue à Paris!
16:00 - 17:00Networking
Level 0, Hall A, Booth #50
Join us in Paris at BIO-Europe Spring 2020, March23–25, 2020
SESSIONSDAY 3 - 27/03/2019
BIO-Europe SpringMarch 25–27, 2019
Messe Wien Exhibition and Congress CenterVienna, Austria
+49 89 2388 756 0 ebdgroup.knect365.com/bioeurope-spring/ conferences@ebdgroup.com
TIME ADDITIONALPROGRAM
COMPANY PRE-SENTATIONS
EXTRA ACTIVITY LABIOTECH RE-FRESH EVENT
MAIN AGENDA NETWORKING PARTNERING POWER UP PART-NERINGONE
SPOTLIGHT ONMICROBIOME
TRANSPORTA-TION TO AIRPORT
07:00 07:45 - Registra-tion and Exhibi-tion Open
07:45 - Continen-tal Breakfast
08:00 08:00 - One-to-one meetings
09:00 09:00 - HTA ses-sion/IGES: Howdoes Europe setthe price for anew drug?
09:30 - CompanyPresentations
09:30 - Power uppartneringONE:Essentials (plusExperienced)
09:00 - Gut in-stincts: Latestpartnerships andcollaborationmodels in micro-biome
10:00
11:00 11:00 - Pre-ConferenceWorkshop: Navi-gating the regu-latory landscapefor microbiometherapeutics
11:05 - BREAKAND BREATHE
11:35 - BREAKAND BREATHE
11:30 - Power uppartneringONE:Experienced
12:00 12:00 - Luncheon
13:00 13:00 - Pre-ConferenceWorkshop: Navi-gating the regu-latory landscapefor microbiometherapeutics
SCHEDULEDAY 3 - 27/03/2019
BIO-Europe SpringMarch 25–27, 2019
Messe Wien Exhibition and Congress CenterVienna, Austria
+49 89 2388 756 0 ebdgroup.knect365.com/bioeurope-spring/ conferences@ebdgroup.com
TIME ADDITIONALPROGRAM
COMPANY PRE-SENTATIONS
EXTRA ACTIVITY LABIOTECH RE-FRESH EVENT
MAIN AGENDA NETWORKING PARTNERING POWER UP PART-NERINGONE
SPOTLIGHT ONMICROBIOME
TRANSPORTA-TION TO AIRPORT
14:00 14:00 - Session1: The 5 mostimportant up-coming trends inEuropeanbiotech
14:50 - Session2: What's lyingahead for Euro-pean biotech in2019 and beyond
14:00 - Buses toairport
15:00
16:00 16:00 - Baba(Goodbye) Vien-na – Bienvenue àParis!
SCHEDULEDAY 3 - 27/03/2019
BIO-Europe SpringMarch 25–27, 2019
Messe Wien Exhibition and Congress CenterVienna, Austria
+49 89 2388 756 0 ebdgroup.knect365.com/bioeurope-spring/ conferences@ebdgroup.com
MICROBIOME THERAPEUTICS 28-29 March2019
09:00 - 19:00SIDE EVENT 1
Connecting The Dots From Discovery ToCommercialisation
Advance Your Translational Human MicrobiomeResearch, Clinical Trials, Emerging Technology,Manufacturing and Regulatory Acumen
28 - 29 March 2019
FIND OUT MORE
Vienna Biocenter Tour
09:00 - 13:30Site Tour 1
For BIO-Europe Spring attendees only: Trip to theVienna BioCenter
Make the most out of your stay in Vienna and join thisunique tour to one of Europe’s biggest life scienceshubs.
BIO-Europe Spring attendees have the chance to joinsite visits to learn more about Vienna’s life sciencecommunity. Winners of the Start Alliance program“Discover Vienna: Life Sciences”, operated incollaboration with the Vienna Business Agency, areespecially encouraged to make use of this greatopportunity.
The number of participants is limited. Registration ismandatory.
Click Here To Register
Trip to the Vienna BioCenter
Preliminary program
9:00 am – Bus pick up at Messe Wien
9:30 am – Welcome Valneva Austria GmbH
9:40 am – Vienna Business Agency and LISAvienna
10:00 am – Introduction Vienna BioCenter
10:20 am – Coffee break
10:40 am – Introduction Vienna BioCenter CoreFacilities
11:00 am – Campus tour
12:15 pm - Networking lunch with companies andinstitutes from Vienna Biocenter
1:30 pm - Bus back to Messe Wien
Boehringer Ingelheim Tour
09:00 - 13:30Site Tour 2
Boehringer Ingelheim invites you to tour itsfacility in Vienna on Thursday, March 28th
Boehringer Ingelheim, one of the world’s leadingcontract development and manufacturingorganizations for biopharmaceuticals invites you totour its facility in Vienna on Thursday, March 28th. Abus pick-up will be at Messe Vienna at 9:00 a.m.
This is a chance to explore and witness ourbiopharmaceutical manufacturing, highest qualitystandards and overall excellence. In addition, you willhave the opportunity to meet with site and technologyexperts, and discuss potential partnerships.
The guided tour of the Boehringer Ingelheim state-of-the-art facility will show you our core capabilities ascenter of excellence in process development andmanufacturing of biopharmaceuticals using microbialbased technologies.
With the currently ongoing constructions to establish alarge scale cell culture facility the site will be the onlymember in Boehringer Ingelheim’s biopharmaceuticalmanufacturing network offering variousmanufacturing technologies. Visitors will gain insightsinto both capabilities of Boehringer Ingelheim RCV. Formore information please visit www.boehringer-ingelheim.at
Following the tour and prior to returning by bus back toMesse Vienna at 01:30 pm, you will have the chance tofurther network over lunch.
Space is limited so RSVP today atoffice@LISAvienna.at!
SESSIONSPOST-EVENT PROGRAMS - 28/03/2019
BIO-Europe SpringMarch 25–27, 2019
Messe Wien Exhibition and Congress CenterVienna, Austria
+49 89 2388 756 0 ebdgroup.knect365.com/bioeurope-spring/ conferences@ebdgroup.com
TIME SIDE EVENT 1 SITE TOUR 1 SITE TOUR 2
09:00 09:00 - MICROBIOME THERAPEUTICS28-29 March 2019
09:00 - Vienna Biocenter Tour 09:00 - Boehringer Ingelheim Tour
SCHEDULEPOST-EVENT PROGRAMS - 28/03/2019
BIO-Europe SpringMarch 25–27, 2019
Messe Wien Exhibition and Congress CenterVienna, Austria
+49 89 2388 756 0 ebdgroup.knect365.com/bioeurope-spring/ conferences@ebdgroup.com
Recommended